A citation-based method for searching scientific literature


List of co-cited articles
213 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
Jaishree Jalewa, Mohit Kumar Sharma, Simon Gengler, Christian Hölscher. Neuropharmacology 2017
50
5

Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes.
Maka S Hedrington, Ana Tsiskarishvili, Stephen N Davis. Expert Opin Biol Ther 2018
12
8

Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
M M Migliore, R Ortiz, S Dye, R B Campbell, M M Amiji, B L Waszczak. Neuroscience 2014
63
5

Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?
O Schulte-Herbrüggen, A Braun, S Rochlitzer, M C Jockers-Scherübl, R Hellweg. Curr Med Chem 2007
81
5

Trophic factor gene therapy for Parkinson's disease.
Jeffrey H Kordower, Anders Bjorklund. Mov Disord 2013
98
5

DA-JC1 improves learning and memory by antagonizing Aβ31-35-induced circadian rhythm disorder.
Li Wang, Rui Zhang, Xiaohong Hou, Changtu Wang, Shuai Guo, Na Ning, Cong Sun, Yuan Yuan, Lin Li, Christian Hölscher,[...]. Mol Brain 2019
6
16

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.
Alan Whone, Matthias Luz, Mihaela Boca, Max Woolley, Lucy Mooney, Sonali Dharia, Jack Broadfoot, David Cronin, Christian Schroers, Neil U Barua,[...]. Brain 2019
146
5


Synaptic dysfunction in Parkinson's disease.
Barbara Picconi, Giovanni Piccoli, Paolo Calabresi. Adv Exp Med Biol 2012
154
5

Mechanisms of action of glucagon-like peptide 1 in the pancreas.
Máire E Doyle, Josephine M Egan. Pharmacol Ther 2007
430
5



An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function.
Amber D Van Laar, Victor S Van Laar, Waldy San Sebastian, Aristide Merola, J Bradley Elder, Russell R Lonser, Krystof S Bankiewicz. J Parkinsons Dis 2021
6
16

Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice.
Simon Gengler, Paula L McClean, Ruth McCurtin, Victor A Gault, Christian Hölscher. Neurobiol Aging 2012
140
5

Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.
Mathew Blurton-Jones, Masashi Kitazawa, Hilda Martinez-Coria, Nicholas A Castello, Franz-Josef Müller, Jeanne F Loring, Tritia R Yamasaki, Wayne W Poon, Kim N Green, Frank M LaFerla. Proc Natl Acad Sci U S A 2009
579
5

Disease modifying therapy for AD?
Todd E Golde. J Neurochem 2006
94
5


Nerve growth factor, neural stem cells and Alzheimer's disease.
Klaus Heese, Jin Wei Low, Noriko Inoue. Neurosignals 2006
70
5


Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats.
Wei-Na Han, Christian Hölscher, Li Yuan, Wei Yang, Xiao-Hui Wang, Mei-Na Wu, Jin-Shun Qi. Neurobiol Aging 2013
106
5

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.
L F Lin, D H Doherty, J D Lile, S Bektesh, F Collins. Science 1993
5

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
5


β-Amyloid impairs axonal BDNF retrograde trafficking.
Wayne W Poon, Mathew Blurton-Jones, Christina H Tu, Leila M Feinberg, Meredith A Chabrier, Joe W Harris, Noo Li Jeon, Carl W Cotman. Neurobiol Aging 2011
133
5



Exploring the pathogenesis of IIH: an inflammatory perspective.
Alexandra J Sinclair, Alexandra K Ball, Michael A Burdon, Carl E Clarke, Paul M Stewart, S John Curnow, Saaeha Rauz. J Neuroimmunol 2008
65
5

Normal aging induces A1-like astrocyte reactivity.
Laura E Clarke, Shane A Liddelow, Chandrani Chakraborty, Alexandra E Münch, Myriam Heiman, Ben A Barres. Proc Natl Acad Sci U S A 2018
586
5

Peptides and the blood-brain barrier.
William A Banks. Peptides 2015
59
5

Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
Steven Bradburn, Christopher Murgatroyd, Nicola Ray. Ageing Res Rev 2019
92
5

Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor.
Jia Shi, Bo Dong, Yumin Mao, Wei Guan, Jiachao Cao, Rongxing Zhu, Suinuan Wang. Oncotarget 2016
52
5

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.
TracyAnn Perry, Harold W Holloway, Ananda Weerasuriya, Peter R Mouton, Kara Duffy, Julie A Mattison, Nigel H Greig. Exp Neurol 2007
154
5

Astrocytes: Key Regulators of Neuroinflammation.
Emanuela Colombo, Cinthia Farina. Trends Immunol 2016
446
5


The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects.
Hongxiang Hui, Loredana Farilla, Patricia Merkel, Riccardo Perfetti. Eur J Endocrinol 2002
90
5

Glucagon like peptide-1 (GLP-1) likes Alzheimer's disease.
Ilgin Yildirim Simsir, Utku Erdem Soyaltin, Sevki Cetinkalp. Diabetes Metab Syndr 2018
42
5

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.
Shuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, Kyoko Sawada, Takanori Kunieda, Daisuke Takeuchi, Hitomi Kurinami, Mitsuru Shinohara, Hiromi Rakugi, Ryuichi Morishita. Proc Natl Acad Sci U S A 2010
382
5

Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents.
Takashi Iwai, Toshihiro Sawabe, Kahori Tanimitsu, Manabu Suzuki, Sachie Sasaki-Hamada, Jun-Ichiro Oka. J Neurosci Res 2014
35
5

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease.
Dawling A Dionisio-Santos, John A Olschowka, M Kerry O'Banion. J Neuroinflammation 2019
84
5

Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Ga Eun Nam, Seon Mee Kim, Kyungdo Han, Nan Hee Kim, Hye Soo Chung, Jin Wook Kim, Byoungduck Han, Sung Jung Cho, Ji Hee Yu, Yong Gyu Park,[...]. PLoS Med 2018
66
5

Neuroinflammation: the devil is in the details.
Damon J DiSabato, Ning Quan, Jonathan P Godbout. J Neurochem 2016
533
5

Insulin receptor mRNA in the substantia nigra in Parkinson's disease.
M Takahashi, T Yamada, I Tooyama, I Moroo, H Kimura, T Yamamoto, H Okada. Neurosci Lett 1996
95
5

Waist circumference and risk of Parkinson's disease.
Kye-Yeung Park, Ga Eun Nam, Kyungdo Han, Hoon-Ki Park, Hwan-Sik Hwang. NPJ Parkinsons Dis 2022
2
50

Etanercept, an inhibitor of TNF-a, prevents propofol-induced neurotoxicity in the developing brain.
Bo Chen, Xiaoyuan Deng, Bin Wang, Hongliang Liu. Int J Dev Neurosci 2016
23
5

What is a pericyte?
David Attwell, Anusha Mishra, Catherine N Hall, Fergus M O'Farrell, Turgay Dalkara. J Cereb Blood Flow Metab 2016
334
5

Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Mahip K Verma, Rajan Goel, Nandakumar Krishnadas, Kumar V S Nemmani. Expert Opin Ther Targets 2018
15
6

Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss.
Maarja A Mäe, Liqun He, Sofia Nordling, Elisa Vazquez-Liebanas, Khayrun Nahar, Bongnam Jung, Xidan Li, Bryan C Tan, Juat Chin Foo, Amaury Cazenave-Gassiot,[...]. Circ Res 2021
44
5

The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells.
Marit Pedersen Delghandi, Mona Johannessen, Ugo Moens. Cell Signal 2005
241
5

Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.
Nigel H Greig, David Tweedie, Lital Rachmany, Yazhou Li, Vardit Rubovitch, Shaul Schreiber, Yung-Hsiao Chiang, Barry J Hoffer, Jonathan Miller, Debomoy K Lahiri,[...]. Alzheimers Dement 2014
55
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.